Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T N Krasnova

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Terapevticheskii Arkhiv|August 19, 2015
[Impact of interleukin-10 and interleukin-28 gene polymorphisms on the development and course of lupus nephritis]T N Krasnova, L M Samokhodskaya, L V Ivanitsky, et al.
Terapevticheskii Arkhiv|July 20, 2000
[Primary focal segmental glomerulosclerosis: clinical and morphological prognostic factors]E M Shilov, I E Tareeva, A A Ivanov, et al.
Terapevticheskii Arkhiv|September 25, 2012
[Remodeling of the cardiovascular system and development of chronic kidney disease in patients with metabolic syndrome and obesity: role of eNOS, subunit p22-phox of NADPH-oxidase and MTHFR genes]E A Saginova, M G Galliamov, A V Balatskiĭ, et al.
Terapevticheskii Arkhiv|July 26, 2002
[The course and prognosis of mesangioproliferative glomerulonephritis]E M Shilov, I E Tareeva, A A Ivanov, et al.
Kardiologiia|July 29, 2020
[Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)]V Yu Mareev, Ya A Orlova, E P Pavlikova, et al.
Kardiologiia|March 18, 2021
Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT studyV Yu Mareev, Ya A Orlova, A G Plisyk, et al.
Kardiologiia|January 13, 2023
Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19)V Yu Mareev, Yа A Orlova, A G Plisuk, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Terapevticheskii Arkhiv|August 19, 2015
[Impact of interleukin-10 and interleukin-28 gene polymorphisms on the development and course of lupus nephritis]T N Krasnova, L M Samokhodskaya, L V Ivanitsky, et al.
Terapevticheskii Arkhiv|July 20, 2000
[Primary focal segmental glomerulosclerosis: clinical and morphological prognostic factors]E M Shilov, I E Tareeva, A A Ivanov, et al.
Terapevticheskii Arkhiv|September 25, 2012
[Remodeling of the cardiovascular system and development of chronic kidney disease in patients with metabolic syndrome and obesity: role of eNOS, subunit p22-phox of NADPH-oxidase and MTHFR genes]E A Saginova, M G Galliamov, A V Balatskiĭ, et al.
Terapevticheskii Arkhiv|July 26, 2002
[The course and prognosis of mesangioproliferative glomerulonephritis]E M Shilov, I E Tareeva, A A Ivanov, et al.
Kardiologiia|July 29, 2020
[Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)]V Yu Mareev, Ya A Orlova, E P Pavlikova, et al.
Kardiologiia|March 18, 2021
Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT studyV Yu Mareev, Ya A Orlova, A G Plisyk, et al.
Kardiologiia|January 13, 2023
Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19)V Yu Mareev, Yа A Orlova, A G Plisuk, et al.
Pageof 4